(Q48148420)

English

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

restless legs syndrome

1 reference

based on heuristic

inferred from title

Juliane Winkelmann

10

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Claudia Trenkwalder

1

object named as

Claudia Trenkwalder

1 reference

Europe PubMed Central

9 February 2018

5

object named as

Birgit Högl

1 reference

Europe PubMed Central

9 February 2018

Richard P Allen

11

object named as

Richard P Allen

1 reference

Europe PubMed Central

9 February 2018

author name string

Heike Beneš

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Ludger Grote

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Diego García-Borreguero

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Michael Hopp

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Björn Bosse

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Alexander Oksche

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Karen Reimer

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Ralf Kohnen

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

RELOXYN Study Group

13

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

publication date

18 October 2013

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Lancet Neurology

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

1141-1150

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation as a treatment complication of restless legs syndrome: concept and management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Update to the AASM Clinical Practice Guideline: "The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Methadone for refractory restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up on restless legs syndrome patients treated with opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychometric properties of the Medical Outcomes Study Sleep measure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An item response analysis of the international restless legs syndrome study group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrathecal morphine as a treatment for refractory restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of medically refractory restless legs syndrome with intrathecal morphine: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall self-perceived health in Restless legs treated with intrathecal morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Restless legs syndrome augmentation associated with tramadol.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation of restless legs syndrome with long-term tramadol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of opioids and naloxone on rhythmic motor activity in spinal cats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine and the spinal cord in restless legs syndrome: Does spinal cord physiology reveal a basis for augmentation?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin enacarbil: in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970239-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(13)70239-4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/24140442

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48148420&oldid=1519539311"